GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioNxt Solutions Inc (XCNQ:BNXT) » Definitions » Price-to-Free-Cash-Flow

BioNxt Solutions (XCNQ:BNXT) Price-to-Free-Cash-Flow : N/A (As of Jun. 06, 2024)


View and export this data going back to 2019. Start your Free Trial

What is BioNxt Solutions Price-to-Free-Cash-Flow?

As of today (2024-06-06), BioNxt Solutions's share price is C$0.35. BioNxt Solutions's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.02. Hence, BioNxt Solutions's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for BioNxt Solutions's Price-to-Free-Cash-Flow or its related term are showing as below:

XCNQ:BNXT's Price-to-Free-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 22.885
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

BioNxt Solutions's Free Cash Flow per Share for the three months ended in Mar. 2024 was C$-0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was C$-0.02.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 33.20% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -19.90% per year.

During the past 6 years, BioNxt Solutions's highest 3-Year average Free Cash Flow per Share Growth Rate was 33.20% per year. The lowest was -133.80% per year. And the median was 4.10% per year.


BioNxt Solutions Price-to-Free-Cash-Flow Historical Data

The historical data trend for BioNxt Solutions's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNxt Solutions Price-to-Free-Cash-Flow Chart

BioNxt Solutions Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - - - -

BioNxt Solutions Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BioNxt Solutions's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, BioNxt Solutions's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioNxt Solutions's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioNxt Solutions's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where BioNxt Solutions's Price-to-Free-Cash-Flow falls into.



BioNxt Solutions Price-to-Free-Cash-Flow Calculation

BioNxt Solutions's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.35/-0.021
=N/A

BioNxt Solutions's Share Price of today is C$0.35.
BioNxt Solutions's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.02.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

BioNxt Solutions  (XCNQ:BNXT) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


BioNxt Solutions Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of BioNxt Solutions's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


BioNxt Solutions (XCNQ:BNXT) Business Description

Traded in Other Exchanges
Address
1820 Fir Street, Suite 270, Vancouver, BC, CAN, V6J 3B1
BioNxt Solutions Inc is a cannabis company engaged in developing analytical testing, processing, and formulation capability in Canada. It is also engaged in research, cultivation, extraction, import, distribution, and manufacturing in Germany. The products of the company include Drug Delivery, Point-of-Care Diagnostics, and Psychedelics.

BioNxt Solutions (XCNQ:BNXT) Headlines

No Headlines